Biotech's current depression has begun to take a very human toll. While the specific stories behind each of the CEO exits in the accompanying table are all different, most would not have occurred had the stock market been a friendlier environment.
You may also be interested in...
The Dutch start-up will use the funds to finalize product design for a neurostimulation platform targeting chronic migraines.
Signifier Medical Technologies is ramping up commercialization of its technology solutions for patients with snoring and sleep disordered breathing conditions.
Jeff Shuren, director of the US FDA’s device center, says the agency is working on a draft guidance document that will give industry recommendations on how it should handle products granted emergency use authorization during the COVID-19 public health emergency. The guidance will also address already-approved devices that were modified by their makers under enforcement discretion.